Your shopping cart is currently empty

VVD-849 is a RAS ligand that covalently binds to cysteine at position 242 within the RAS binding domain of PI3Kp110α, enhancing RAS/PI3K interaction. It partially inhibits pAKT(S473) in tumors overexpressing HER2. VVD-849 is applicable in cancer research, including studies on breast cancer.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | VVD-849 is a RAS ligand that covalently binds to cysteine at position 242 within the RAS binding domain of PI3Kp110α, enhancing RAS/PI3K interaction. It partially inhibits pAKT(S473) in tumors overexpressing HER2. VVD-849 is applicable in cancer research, including studies on breast cancer. |
| Molecular Weight | 636.15 |
| Formula | C29H31ClFN3O6S2 |
| Cas No. | 3055321-14-4 |
| Smiles | S(=O)(=O)(C1=C(C=C(Cl)C=C1)C2=CC(OCC3=CC=CC=N3)=CC=C2)N4CCC(C(N[C@H](/C=C\S(C)(=O)=O)C)=O)(F)CC4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.